BioNexus Gene Lab Corp. (BGLC)
1.40
-0.05
(-3.45%)
USD |
NASDAQ |
Sep 08, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Debt to Equity Ratio : 0.0255 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0255 |
| March 31, 2026 | 0.0267 |
| December 31, 2025 | 0.0204 |
| September 30, 2025 | 0.027 |
| June 30, 2025 | 0.0262 |
| March 31, 2025 | 0.0257 |
| December 31, 2024 | 0.0253 |
| September 30, 2024 | 0.0241 |
| June 30, 2024 | 0.0247 |
| March 31, 2024 | 0.013 |
| December 31, 2023 | 0.0138 |
| September 30, 2023 | 0.0143 |
| June 30, 2023 | 0.0077 |
| March 31, 2023 | 0.008 |
| December 31, 2022 | 0.0085 |
| September 30, 2022 | 0.004 |
| June 30, 2022 | 0.0046 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0101 |
| December 31, 2021 | 0.0107 |
| September 30, 2021 | 0.0122 |
| June 30, 2021 | 0.0143 |
| March 31, 2021 | 0.016 |
| December 31, 2020 | 0.0185 |
| September 30, 2020 | 0.08 |
| June 30, 2020 | 0.0773 |
| March 31, 2020 | 0.0751 |
| December 31, 2019 | 0.0797 |
| September 30, 2019 | 0.0543 |
| June 30, 2019 | 0.0533 |
| March 31, 2019 | 0.0531 |
| December 31, 2018 | 0.0539 |
| September 30, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Intertek Group Plc | -- |
| ALS Ltd. | -- |
| Capital A Bhd. | 3.172 |
| AECOM | 1.519 |
| Exponent, Inc. | 0.2797 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.726M |
| Total Liabilities (Quarterly) | 0.948M |
| Shareholders Equity (Quarterly) | 7.778M |
| Current Ratio | 6.081 |
| Net Debt Paydown Yield | 0.01% |